The forecast for the hospital average length of stay for dermatitis, eczema, and papulosquamous disorders in Germany shows a gradual reduction from 10.8 days in 2024 to 10.2 days in 2028. Comparing to 2023 figures, the average stay was 10.9 days, indicating a consecutive annual decrease. The year-on-year decrease is approximately 0.93% from 2024 to 2025, 1.87% from 2025 to 2026, 0.95% from 2026 to 2027, and 1.92% from 2027 to 2028. Over the five-year forecasted period from 2024 to 2028, the compound annual growth rate (CAGR) is a decline of around 1.44% per year.
Future trends to watch include advancements in medical technology and treatments that might continue to reduce hospital stays. Additionally, an increased focus on outpatient care and home treatment options could further decrease average stay durations. Health policy shifts and innovations in dermatological care will also play crucial roles in determining future trends. Furthermore, demographic changes and potential fluctuations in disease prevalence could impact length of stay in the coming years.
